A phase I/II study of ALIMTA [pemetrexed] plus oxaliplatin administered every other week in the treatment of patients with metastatic cancer.

Trial Profile

A phase I/II study of ALIMTA [pemetrexed] plus oxaliplatin administered every other week in the treatment of patients with metastatic cancer.

Completed
Phase of Trial: Phase I

Latest Information Update: 14 Apr 2011

At a glance

  • Drugs Oxaliplatin (Primary) ; Pemetrexed (Primary)
  • Indications Lymphoma; Solid tumours
  • Focus Adverse reactions
  • Most Recent Events

    • 12 May 2008 Status changed from in progress to completed.
    • 22 Jan 2008 Status changed from recruiting to in progress according to ClinicalTrials.gov.
    • 20 Jun 2007 Status changed from initiated to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top